Page last updated: 2024-08-23

epirubicin and Body Weight

epirubicin has been researched along with Body Weight in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19904 (23.53)18.7374
1990's6 (35.29)18.2507
2000's2 (11.76)29.6817
2010's3 (17.65)24.3611
2020's2 (11.76)2.80

Authors

AuthorsStudies
Chen, ZJ; Li, H; Li, N; Wang, N; Zhang, C; Zhu, Y1
Chen, E; Han, S; Liang, M; Song, B; Sun, Y; Xu, L; Yuan, H1
Chen, H; Dai, Y; Feng, X; Li, X; Liu, L; Liu, X; Tang, H; Zhang, Q; Zhang, T; Zhou, Z; Zhuang, T1
Chen, G; Ding, Q; Fan, J; Fang, ZJ; Geng, J; Jiang, HW; Sun, JL; Wang, X1
Nordenhem, A; Norrby, K1
Gilani, SQ; Jain, PK; Pellen, MG; Razack, A; Sabri, S1
Barletta, E; Bruni, GS; D'Angelo, R; Daniele, B; Ferrari, E; Fiore, F; Formato, R; Iaffaioli, RV; Ottaiano, A; Pignata, S; Tortoriello, A; Turitto, G1
Cosolo, WC; McKendrick, JJ; Morgan, DJ; Seeman, E; Zalcberg, JR; Zimet, AS1
Karakiulakis, G; Paradelis, AG; Pispirigos, K1
Barni, S; Battelli, N; Casaretti, R; Cascinu, S; Catalano, G; Cellerino, R; Comella, G; Frontini, L; Labianca, R; Pirovano, M; Zonato, S1
Bengtsson, NO; Eksborg, S; Elfsson, B; Hardell, L; Sjödin, M1
Araki, Y; Gomita, Y; Shinozawa, S1
Bergan, A; Clausen, OP; Hall, KS; Lien, B; Mørkrid, L; Rugstad, HE1
Dardir, M; Ferrans, VJ; Herman, EH1
Hopewell, JW; Simmonds, RH; Yeung, TK1
Björkman, S; Elisson, LO1
Antongiovanni, V; Balconi, F; Ballerini, L; Bertazzoli, C; Lux, B; Magrini, U; Rovero, C1

Trials

3 trial(s) available for epirubicin and Body Weight

ArticleYear
Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.
    Frontiers in bioscience : a journal and virtual library, 2006, Jan-01, Volume: 11

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome

2006
Lean body mass, body surface area and epirubicin kinetics.
    Anti-cancer drugs, 1994, Volume: 5, Issue:3

    Topics: Body Mass Index; Body Surface Area; Body Weight; Epirubicin; Humans; Neoplasms; Spectrophotometry, Atomic

1994
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
    British journal of cancer, 1999, Volume: 79, Issue:3-4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lenograstim; Leucovorin; Male; Middle Aged; Pain; Palliative Care; Pancreatic Neoplasms; Recombinant Proteins; Survival Analysis; Treatment Outcome

1999

Other Studies

14 other study(ies) available for epirubicin and Body Weight

ArticleYear
Melatonin protects against Epirubicin-induced ovarian damage.
    The Journal of reproduction and development, 2020, Feb-14, Volume: 66, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Body Weight; Caspase 3; Caspase 9; Endoplasmic Reticulum Stress; Epirubicin; Estradiol; Female; Melatonin; Mice; Mice, Inbred ICR; Ovary; Oxidative Stress; Progesterone; Protective Agents; Reactive Oxygen Species; Uterus

2020
Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Drug Carriers; Endocytosis; Epirubicin; Humans; Hyaluronoglucosaminidase; Ki-67 Antigen; Male; Mice, Nude; Nanoparticles; Neoplasms; Polymers; Spheroids, Cellular; Tumor Burden; Tumor Microenvironment

2020
Stability, Pharmacokinetics, Biodistribution and Safety Assessment of Folate-Conjugated Pullulan Acetate Nanoparticles as Cervical Cancer Targeted Drug Carriers.
    Journal of nanoscience and nanotechnology, 2015, Volume: 15, Issue:9

    Topics: Animals; Antineoplastic Agents; Body Weight; Drug Carriers; Drug Stability; Epirubicin; Female; Folic Acid; Glucans; HeLa Cells; Humans; Male; Mice; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Rats, Wistar; Tissue Distribution; Uterine Cervical Neoplasms

2015
Elevated serum soluble Fas ligand is a promising marker of testicular toxicity induced by epirubicin in rats.
    Toxicology letters, 2009, Apr-25, Volume: 186, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Blotting, Western; Body Weight; Enzyme-Linked Immunosorbent Assay; Epirubicin; Fas Ligand Protein; fas Receptor; Immunohistochemistry; In Situ Nick-End Labeling; Male; Organ Size; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; Testicular Diseases; Testis

2009
Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2010, Volume: 118, Issue:12

    Topics: Animals; Antibiotics, Antineoplastic; Anticoagulants; Body Weight; Dalteparin; Epirubicin; Immunohistochemistry; Infusions, Subcutaneous; Male; Mesenteric Arteries; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Vascular Endothelial Growth Factor A

2010
Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2012, Volume: 25, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Deglutition Disorders; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Malnutrition; Middle Aged; Neoadjuvant Therapy; Prosthesis Failure; Serum Albumin; Severity of Illness Index; Stents

2012
Evaluation of cardiac subacute toxicity of epirubicin, chlorambucil, cisplatin, methotrexate and a homo-aza-steroid ester with antitumor activity in rats using serum biochemical parameters.
    Arzneimittel-Forschung, 1997, Volume: 47, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Aspartate Aminotransferases; Body Weight; Chlorambucil; Cisplatin; Creatine Kinase; Epirubicin; Heart Diseases; Isoenzymes; L-Lactate Dehydrogenase; Methotrexate; Rats

1997
Epirubicin as a single agent therapy for the treatment of breast cancer--a pharmacokinetic and clinical study.
    Medical oncology and tumor pharmacotherapy, 1992, Volume: 9, Issue:2

    Topics: Adult; Aged; Body Weight; Breast Neoplasms; Epirubicin; Female; Humans; Middle Aged; Neoplasm Metastasis; Obesity; Remission Induction

1992
[Effects of anthracycline drugs (aclarubicin, daunorubicin, doxorubicin, epirubicin, pirarubicin) on mouse acute toxicity and rat liver microsomal lipid peroxidation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6

    Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Body Weight; Daunorubicin; Doxorubicin; Epirubicin; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Microsomes, Liver; Mitochondria, Liver; Rats; Rats, Inbred Strains

1992
Long-term toxicity of preoperative 4'-epidoxorubicin (Epi-adriamycin) in partially hepatectomized rats.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1991, Volume: 23, Issue:2

    Topics: Animals; Blood Chemical Analysis; Body Weight; Dose-Response Relationship, Drug; Epirubicin; Hepatectomy; Liver; Male; Organ Size; Premedication; Preoperative Care; Rats; Rats, Inbred BUF; Survival Analysis; Time Factors

1991
Effects of ICRF-187 on the cardiac and renal toxicity of epirubicin in spontaneously hypertensive rats.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:5

    Topics: Animals; Blood Pressure; Body Weight; Drug Evaluation, Preclinical; Drug Interactions; Epirubicin; Heart; Kidney; Male; Microscopy, Electron; Myocardium; Piperazines; Rats; Rats, Inbred SHR; Razoxane; Stereoisomerism

1989
A functional assessment of the relative cardiotoxicity of adriamycin and epirubicin in the rat.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1989, Volume: 15, Issue:3

    Topics: Animals; Body Weight; Cardiac Output; Doxorubicin; Epirubicin; Heart; Lethal Dose 50; Male; Rats; Rats, Inbred Strains

1989
Congestive heart failure in rabbits after a single intrapleural administration of a low dose of doxorubicin or epirubicin.
    Pharmacology & toxicology, 1988, Volume: 62, Issue:2

    Topics: Animals; Body Weight; Doxorubicin; Epirubicin; Female; Heart Failure; Injections; Male; Pleura; Rabbits

1988
Experimental systemic toxicology of 4'-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agent.
    Toxicology and applied pharmacology, 1985, Volume: 79, Issue:3

    Topics: Animals; Antineoplastic Agents; Body Weight; Dogs; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Epirubicin; Erythrocyte Count; Female; Heart; Lethal Dose 50; Leukocyte Count; Liver; Liver Function Tests; Male; Mice; Mice, Inbred Strains; Organ Size; Proteinuria; Rats; Rats, Inbred Strains; Testis; Thymus Gland

1985